CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
How we can help
Please check our individual program pages for any service changes due to COVID-19.
If you have stopped working because of COVID-19, the Canada Emergency Response Benefit (CERB) may provide you with temporary income support. You may also qualify for other nationwide or regional financial support programs.
If you, or someone you care about has been diagnosed with cancer, you’ll have many questions and concerns. We’re here to help. We offer a support system for people with cancer and their family, friends and caregivers.
Fear, anxiety, helplessness, anger – these are feelings people can have when faced with a cancer diagnosis. But knowledge and support are power. Our services are free and confidential, and many are available in multiple languages.
Find support from someone who’s been there
Our online community – CancerConnection.ca –helps people who have cancer, cancer survivors and caregivers share their experiences and build supportive relationships.
Find answers to your questions about cancer
Our Cancer Information Helpline provides answers to questions about all types of cancer, diagnostic tests, treatments, side effects, clinical trials and many other cancer-related topics.
From diagnosis to treatment to life after cancer, we're here to provide reliable and up-to-date information that's easy to understand. Explore our wide range of downloadable booklets.
Other ways we can help
We can also help you find more cancer-related services in your area through our Community Services Locator – a searchable database of over 4000 cancer-related services and resources nationwide – or at one of our community offices across the country.
Quit smoking – Our Smokers’ Helpline offers proven tips and tools to help people quit smoking.
Reducing the burden of cancer
Canadians can help CCS fund the best research and support people living with cancer by donating and volunteering.